ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 176 filers reported holding ARGENX SE in Q2 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,039,871 | +26.1% | 77,375 | 0.0% | 0.27% | +31.4% |
| Q2 2023 | $30,155,359 | +4.6% | 77,375 | 0.0% | 0.21% | -0.5% |
| Q1 2023 | $28,828,378 | -15.2% | 77,375 | -13.8% | 0.21% | -20.0% |
| Q4 2022 | $33,993,552 | +97948.9% | 89,733 | -8.6% | 0.26% | -11.0% |
| Q3 2022 | $34,670 | -99.9% | 98,200 | 0.0% | 0.29% | -7.3% |
| Q2 2022 | $37,206,000 | +20.2% | 98,200 | 0.0% | 0.32% | +66.7% |
| Q1 2022 | $30,963,000 | -10.0% | 98,200 | 0.0% | 0.19% | +2.2% |
| Q4 2021 | $34,389,000 | +16.0% | 98,200 | 0.0% | 0.18% | +9.5% |
| Q3 2021 | $29,656,000 | +0.3% | 98,200 | 0.0% | 0.17% | -5.1% |
| Q2 2021 | $29,565,000 | +156.2% | 98,200 | +134.4% | 0.18% | +140.5% |
| Q1 2021 | $11,539,000 | – | 41,900 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |